IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAROTTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.496
AS - Asia 2.567
EU - Europa 2.441
SA - Sud America 436
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.997
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.409
SG - Singapore 1.256
IT - Italia 642
IE - Irlanda 500
CN - Cina 430
HK - Hong Kong 388
BR - Brasile 367
RU - Federazione Russa 285
UA - Ucraina 232
DE - Germania 200
VN - Vietnam 192
FI - Finlandia 136
KR - Corea 94
SE - Svezia 93
GB - Regno Unito 86
FR - Francia 65
PL - Polonia 58
IN - India 49
CA - Canada 38
AR - Argentina 37
MX - Messico 30
TR - Turchia 29
JP - Giappone 27
NL - Olanda 24
ZA - Sudafrica 21
UZ - Uzbekistan 19
BE - Belgio 18
CH - Svizzera 18
AT - Austria 17
CZ - Repubblica Ceca 17
BD - Bangladesh 15
ES - Italia 13
EC - Ecuador 9
EG - Egitto 9
GR - Grecia 9
IL - Israele 9
LT - Lituania 9
ID - Indonesia 8
AE - Emirati Arabi Uniti 7
IQ - Iraq 7
CO - Colombia 5
MA - Marocco 5
AZ - Azerbaigian 4
CL - Cile 4
DO - Repubblica Dominicana 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
PY - Paraguay 4
VE - Venezuela 4
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
JM - Giamaica 3
LB - Libano 3
MD - Moldavia 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DK - Danimarca 2
PR - Porto Rico 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AU - Australia 1
CG - Congo 1
DJ - Gibuti 1
DM - Dominica 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NE - Niger 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 8.994
Salva come PNG Salva come JPEG
Città #
Singapore 835
Dublin 500
Chandler 483
Hong Kong 385
Perugia 272
San Mateo 222
Ashburn 198
Boardman 181
Santa Clara 170
Medford 116
Princeton 115
Altamura 109
Jacksonville 108
Beijing 105
Moscow 98
Wilmington 97
Munich 91
Seoul 90
Lawrence 88
Ann Arbor 81
Los Angeles 70
New York 61
Andover 56
Redmond 56
Dong Ket 50
Ho Chi Minh City 50
Des Moines 36
São Paulo 35
Hanoi 32
Piscataway 32
Kraków 31
Rome 28
Saint Petersburg 28
Warsaw 27
Falls Church 26
Helsinki 26
Dallas 24
The Dalles 22
Tokyo 22
Turku 22
Brooklyn 19
Chennai 18
San Paolo di Civitate 17
Brussels 16
Izmir 16
Montreal 16
Orem 16
Norwalk 15
Boston 14
Chicago 14
Johannesburg 14
Mcallen 14
Phoenix 14
Redwood City 14
Woodbridge 14
Houston 13
Shanghai 12
Spoleto 12
Denver 11
London 11
Milan 11
Poplar 11
Stockholm 11
Atlanta 10
Bologna 10
Fremont 10
Haiphong 10
Hefei 10
Mexico City 10
Nuremberg 10
Tashkent 10
Ankara 9
Cairo 9
Guangzhou 9
Guarulhos 9
Lappeenranta 9
Macerata 9
Rio de Janeiro 9
Toronto 9
Amsterdam 8
Belo Horizonte 8
Brasília 8
Campinas 8
Columbus 8
San Francisco 8
Manchester 7
Biên Hòa 6
Brno 6
Curitiba 6
Da Nang 6
Ness Ziona 6
Porto Alegre 6
Renton 6
San Jose 6
Simi Valley 6
Tübingen 6
Vienna 6
Buenos Aires 5
City of London 5
Fortaleza 5
Totale 5.689
Salva come PNG Salva come JPEG
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 147
Application of the “inverted chirality columns approach” for the monitoring of asymmetric synthesis protocols 124
Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l-Trp to Indoleamine 2,3-Dioxygenase 1 116
Binding properties of different categories of IDO1 inhibitors: A microscale thermophoresis study 110
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 106
Asymmetric synthesis of the four diastereoisomers of a novel non-steroidal farnesoid X receptor (FXR) agonist: Role of the chirality on the biological activity 105
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 103
a-Amino-b-carboxymuconate-e-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of de Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis 103
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 103
One-pot, telescoped synthesis of N-aryl-5-aminopyrazoles from anilines in environmentally benign conditions 102
Cyclopropyl Dafachronic Acid Stereoisomers as Conformationally Constrained DAF-12 Ligands 101
Discovery and Structure–Activity Relationships of Novel ssDAF-12 Receptor Modulators 100
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 100
Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands 98
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 97
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 96
Targeting the FXR nuclear receptor through a virtual screening approach 94
Ion pairing to enhance antibiotic drug efficacy. A new approach to fight problematic infections? 94
An Integrated Approach to Ligand- and Structure-Based Drug Design: Development and Application to a Series of Serine Protease Inhibitors 92
Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches 91
Improved chromatographic diastereoresolution of cyclopropyl dafachronic acid derivatives using chiral anion exchangers 91
Successful rate gain by combination of multiple techniques 90
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 89
Binding models of reversible inhibitors to type-B monoamine oxidase 89
Sequence variants in kynurenine aminotransferase II (KAT II) orthologs determine different potencies of the inhibitor S-ESBA 89
Binding modes identification through molecular dynamic simulations: a case study with carnosine enantiomers and the Teicoplanin A2-2-based chiral stationary phase 89
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 89
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 87
Mixed-mode chromatography characteristics of chiralpak ZWIX(+) and ZWIX(−) and elucidation of their chromatographic orthogonality for LC × LC application 87
Optimized one-pot derivatization and enantioseparation of cysteine: Application to the study of a dietary supplement 87
Fragment-based Design of Zwitterionic, Strong Cation- and Weak Anion-Exchange Type Mixed-mode Liquid Chromatography Ligands and their Chromatographic Exploration 87
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 84
Elucidation of the chromatographic enantiomer elution order through computational studies 83
Hydrophilic interaction liquid chromatography of aminoglycoside antibiotics with a diol-type stationary phase 83
Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists 83
Chromatographic separation of free dafachronic acid epimers with a novel triazole click quinidine-based chiral stationary phase 82
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 82
Chiral mobile phase in ligand-exchange chromatography of amino acids: Exploring the copper(II) salt anion effect with a computational approach 81
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 81
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders 79
Integrating experimental and computational techniques to study chromatographic enantioresolutions of chiral tetrahydroindazole derivatives 79
Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognition. 78
Last ten years (2008–2018) of chiral ligand-exchange chromatography in HPLC: An updated review 78
Atypical enantioseparation of a non-ionic form of allantoin with Cinchona alkaloid-based zwitterionic chiral stationary phases 77
Fluorinated Benzyloxyphenyl Piperidine-4-carboxamides with Dual Function against Thrombosis: Inhibitors of Factor Xa and Platelet Aggregation 77
A Natural Prothrombin Mutant Reveals an Unexpected Influence of A-chain Structure on the Activity of Human {alpha}-Thrombin 77
Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4). 77
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 77
N-Aryl-5-aminopyrazole: A Versatile Architecture in Medicinal Chemistry 77
Targeting the Conformational Transitions of MDM2 and MDMX. PART II: Insights into Key Residues Affecting p53 Recognition. 76
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 76
Microsampling and enantioselective liquid chromatography coupled to mass spectrometry for chiral bioanalysis of novel psychoactive substances 75
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 75
Targeting the FXR Nuclear Receptor through a Virtual Screening Approach 74
Synthesis and Characterization of Chiral Iridium Complexes Bearing Carbohydrate Functionalized Pyridincarboxamide Ligands and Their Application as Catalysts in the Asymmetric Transfer Hydrogenation of α-Ketoacids in Water 73
Quantum mechanics/molecular mechanics (QM/MM) modeling of the irreversible transamination of L-kynurenine to kynurenic acid: The round dance of kynurenine aminotransferase II 73
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 73
4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP) 73
Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome 73
Computational Modeling Overview and Evolution 72
Dissecting the allosteric FXR modulation: A chemical biology approach using guggulsterone as a chemical tool 72
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency 71
New potent and selective FXR agonists: design, synthesis and modeling of norcholanylamine derivatives 71
Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms 71
Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure 71
Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition 70
Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification 69
Enantioseparation of novel anti-inflammatory chiral sulfoxides with two cellulose dichlorophenylcarbamate-based chiral stationary phases and polar-organic mobile phase(s) 69
Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives 68
Insights in the PARP1 poisoning effect 67
Design, synthesis, molecular modeling and biological activity of chenodeoxycholic acid carbamate derivatives as potent and selective FXR agonists 66
A rational approach to elucidate human monoamine oxidase molecular selectivity 66
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 66
Structural Basis of Human Dimeric α-Amino-β-Carboxymuconate-ε-Semialdehyde Decarboxylase Inhibition With TES-1025 66
Environmentally Sustainable Achiral and Chiral Chromatographic Analysis of Amino Acids in Food Supplements 65
Targeting the Conformational Transitions of MDM2 and MDMX. PART I: Insights into Dissimilarities and Similarities of p53 Recognition 65
ENVIRONMENTALLY FRIENDLY, SEQUENTIAL, ONE-POT SYNTHESIS OF N-ARYL-5-AMINOPYRAZOLES FROM ANILINES 64
A journey in unraveling the enantiorecognition mechanism of 3,5-dinitrobenzoyl-amino acids with two Cinchona alkaloid-based chiral stationary phases: The power of molecular dynamic simulations 63
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 63
Efficient enantioresolution of aromatic α-hydroxy acids with Cinchona alkaloid-based zwitterionic stationary phases and volatile polar-ionic eluents 63
Investigation on the Antiplatelet Activity of Pyrrolo[3,2-c]pyridine-Containing Compounds 62
Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity. 62
Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists 62
Molecular Dynamics-Ensemble Docking and Biophysical Studies for Structure-Based Identification of Non-Amino Acidic Ligands of DDAH-1 61
Extending SAR of bile acids as FXR ligands: Discovery of 23-N-(carbocinnamyloxy)-3a,7a-dihydroxy-6a-ethyl-24-nor-5b-cholan-23-amine 60
Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors 60
Effects of Molecular Dynamics and Replica Exchange Molecular Dynamics in Sampling the Conformational Space of PARP-1 60
Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives 59
Exploring the enantiorecognition mechanism of Cinchona alkaloid-based zwitterionic chiral stationary phases and the basic trans-paroxetine enantiomers 59
Synthesis and biological activity of cyclopropyl Δ7-dafachronic acids as DAF-12 receptor ligands 59
Diastereo- and enantioseparation of a Nα-Boc amino acid with a zwitterionic quinine-based stationary phase: Focus on the stereorecognition mechanism 58
Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol 58
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 57
STUDY OF THE MICELLE FORMATION PROCESS OF BILE ACIDS THROUGHMOLECULAR DYAMICS SIMULATIONS 57
The "racemic approach" in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives 57
Enantioseparations by high-performance liquid chromatography based on chiral ligand exchange 57
Elucidation of retention mechanism of dipeptides on a ristocetin A-based chiral stationary phase using a combination of chromatographic and molecular simulation techniques 57
Pyrazole[3,4-e][1,4]thiazepin-7-one Derivatives as a Novel Classo f Farnesoid X Receptor (FXR) Agonists 56
Molecular Doscking and High-Troughput Molecular Dynamics to Detect and Analyze the Binding Site Properties of DAF-12 Orthologs in Parasitic Nematodes 56
High Affinity Central Benzodiazepine Receptor Ligands. Part 3: Insights into the Pharmacophore and Pattern Recognition Study of Intrinsic Activities of Pyrazolo[4,3-c]quinolin-3-ones 55
Totale 7.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021314 0 0 0 0 0 36 54 31 84 15 34 60
2021/2022823 15 132 6 21 15 16 22 285 26 57 96 132
2022/20231.714 126 311 26 124 123 187 7 88 624 17 67 14
2023/2024803 55 106 40 12 11 15 156 29 82 33 120 144
2024/20252.080 39 193 122 79 246 144 146 96 413 133 320 149
2025/20262.411 298 343 236 536 617 381 0 0 0 0 0 0
Totale 9.502